MINNEAPOLIS, Sept. 6, 2011 (GLOBE NEWSWIRE) -- Urologix®, Inc. (Nasdaq:ULGX), the manufacturer and marketer of minimally invasive Cooled ThermoTherapy™ (CTT) for the treatment of BPH, announces the signing of an Exclusive Worldwide License for the Prostiva® RF Therapy System from Medtronic, Inc.(NYSE:MDT). Prostiva RF (Radio Frequency) Therapy is a transurethral needle ablation device that is 510(k) cleared for the treatment of BPH and is most commonly used in the urologist’s office.
